Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Change in Cash (2016 - 2025)

International Stem Cell (ISCO) has disclosed Change in Cash for 16 consecutive years, with $46000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Cash rose 170.59% to $46000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$341000.0, a 177.24% decrease, with the full-year FY2024 number at -$358000.0, down 142.32% from a year prior.
  • Change in Cash was $46000.0 for Q3 2025 at International Stem Cell, up from -$532000.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $439000.0 in Q2 2023 to a low of -$532000.0 in Q2 2025.
  • A 5-year average of $14578.9 and a median of $48000.0 in 2023 define the central range for Change in Cash.
  • Biggest YoY gain for Change in Cash was 209.9% in 2025; the steepest drop was 454.17% in 2025.
  • International Stem Cell's Change in Cash stood at -$334000.0 in 2021, then surged by 122.75% to $76000.0 in 2022, then soared by 107.89% to $158000.0 in 2023, then tumbled by 148.73% to -$77000.0 in 2024, then surged by 159.74% to $46000.0 in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Change in Cash are $46000.0 (Q3 2025), -$532000.0 (Q2 2025), and $222000.0 (Q1 2025).